EUVIMEDEUVIMED entdecken
Crossref

cGAS-STING activation promotes abdominal aortic aneurysm formation in mice and humans: Therapeutic potential of inhibition

Pengcheng Du, Xiaochen Ma, Feixiang Zhu, Guanglang Zhu, Fei Li, Han Nie, Min Yu, Li Tang, Junyi Yan, Yongqiang Li, Yudong Sun, Kai Huang und 2 weitere

Biochemical Pharmacology · 2026-12 · 254 · 118577

DOI: 10.1016/j.bcp.2026.118577 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochemical Pharmacology, 2026-12. Verfasst von Pengcheng Du und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Vascular Surgery, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China. Die Arbeit nennt 58 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Abdominal aortic aneurysm (AAA) is a life-threatening vascular disease lacking effective pharmacotherapy. The cyclic GMP-AMP synthase-stimulator of interferon genes (cGAS-STING) innate immune pathway has been linked to inflammatory conditions, yet its role in AAA remains unclear. Here, we combined single-cell transcriptomics, mouse models, pharmacological inhibition, and human tissue validation to investigate the role of this pathway in AAA. In murine single-cell RNA sequencing (scRNA-seq) data, cGAS-STING activation was predominantly observed in AAA endothelial cells (ECs). Human scRNA-seq and scissor-based classification of stable versus ruptured AAAs showed that cGAS and STING1 were significantly upregulated in ECs from ruptured AAA, implicating pathway activation in rupture risk. Bioinformatic analyses suggested that endothelial cGAS-STING activation correlates with barrier dysfunction and oxidative stress, and that dihydrofolate reductase (DHFR) deficiency may link DNA damage to pathway activation. In Angiotensin II (Ang II) -induced murine AAA, cGAS, p-STING, and p-TBK1 were markedly elevated. Pharmacological blockade with RU.521 (cGAS inhibitor) or STING-IN-2 (STING antagonist) reduced AAA incidence, aortic dilation, and structural damage, while improving endothelial mitochondrial morphology. In human AAA tissues, immunohistochemistry (IHC) confirmed increased cGAS, STING, and TBK1 expression. Moreover, RU.521 or STING-IN-2 treatment of patient-derived 3D AAA organoids significantly downregulated cGAS, p-STING, and p-TBK1, confirming target engagement. Collectively, our findings indicate that the cGAS-STING pathway is activated in murine and human AAA, and that targeting this axis may offer a promising therapeutic approach to limit AAA progression.

Schlagwörter

Stichwörter der Autor:innen

Abdominal aortic aneurysm (AAA)Cyclic GMP-AMP synthase-stimulator of interferon genes (cGAS-STING) pathwayEndothelial dysfunctionHuman AAA explantsSingle-cell transcriptomics

Autor:innen und Institutionen

  • Department of Vascular Surgery, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Institute of Mechanobiology & Medical Engineering, School of Life Sciences & Biotechnology, Shanghai Jiao Tong University, Shanghai, China.
  • Department of Pathology and Frontier Innovation Center, School of Basic Medicine Sciences and Shanghai Pudong Hospital, Fudan University, Shanghai, China.
  • Shanghai Institute of Optics and Fine Mechanics, Chinese Academy of Sciences, Shanghai, China.
  • Department of Vascular Surgery, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China. Electronic address: sunyudong@smmu.edu.cn.
  • Institute of Mechanobiology & Medical Engineering, School of Life Sciences & Biotechnology, Shanghai Jiao Tong University, Shanghai, China. Electronic address: huang_kai@sjtu.edu.cn.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Du, P., Ma, X., Zhu, F., Zhu, G., Li, F., Nie, H., Yu, M., Tang, L., Yan, J., Li, Y., Sun, Y., Huang, K., Yang, H., & Feng, J. (2026). cGAS-STING activation promotes abdominal aortic aneurysm formation in mice and humans: Therapeutic potential of inhibition. Biochemical Pharmacology, 254, 118577. https://doi.org/10.1016/j.bcp.2026.118577

Vancouver

Du P, Ma X, Zhu F, Zhu G, Li F, Nie H, et al. cGAS-STING activation promotes abdominal aortic aneurysm formation in mice and humans: Therapeutic potential of inhibition. Biochemical Pharmacology. 2026;254:118577. doi:10.1016/j.bcp.2026.118577

BibTeX
@article{Du2026,
  author = {Du, Pengcheng and Ma, Xiaochen and Zhu, Feixiang and Zhu, Guanglang and Li, Fei and Nie, Han and Yu, Min and Tang, Li and Yan, Junyi and Li, Yongqiang and Sun, Yudong and Huang, Kai and Yang, Hui and Feng, Jiaxuan},
  title = {cGAS-STING activation promotes abdominal aortic aneurysm formation in mice and humans: Therapeutic potential of inhibition},
  journal = {Biochemical Pharmacology},
  year = {2026},
  volume = {254},
  pages = {118577},
  doi = {10.1016/j.bcp.2026.118577}
}
Kostenlos starten →